CAMBRIDGE, Mass., May 11, 2011 /PRNewswire/ -- The Angiogenesis Foundation has opened early registration for its 2011 Antiangiogenesis Conference that will take place on October 29-30 in Cambridge, MA. The 9th International M. Judah Folkman Conference — New Frontiers in Therapeutic Development attracts key opinion leaders from academia, industry, government, and patient advocacy to discuss the latest information about research and therapeutic development in antiangiogenic therapy for cancer.
Early registration for this high level meeting will close on May 31. To take advantage of discounted early registration rates and to review the preliminary agenda, including topics and speakers, please visit http://www.angio.org/programs-cp-aa11.php.
Antiangiogenic cancer therapy is undergoing explosive growth, with >160 agents in clinical trials and new indications for established therapies. This year's conference will include presentations by leaders from Harvard Medical School, the U.S. National Cancer Institute, Queen's University Belfast, Memorial Sloan Kettering Cancer Center, Stanford University, Tufts University, University of Minnesota, and other top institutions. Past keynote speakers have included: M. Judah Folkman, and Nobel Laureates James D. Watson, Louis J. Ignarro, and H. Robert Horvitz.
Topics to be covered at this year's meeting include:
- Glioblastoma vasculature and stem cells
- Cancer resistance to anti-VEGF therapy
- VEGF-independent tumor angiogenesis
- New biomarker approaches
- Influence of diet on angiogenic signaling pathways
As the world's leading non-profit organization dedicated to advancing the field of angiogenesis research, the Angiogenesis Foundation takes a multidisciplinary approach to its annual conference, bringing together experts and key stakeholders from basic research, life sciences industry, clinical investigation, and government to foster new collaborations and exchanges between faculty and attendees.
Due to limited space, early registration is encouraged. For additional information please contact, Michelle Sylvanowicz at (617) 401-2779.
SOURCE The Angiogenesis Foundation